TCDA Insider Trading Activity and SEC Form 4 Filings
TCDA insider trading summary
No open-market insider purchases or sales of Tricida, Inc. (TCDA) have been reported on SEC Form 4 in the past 12 months.
Latest TCDA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 25, 2022 | Orbimed Advisors LLC | Director | Sell | $798K (3,629,226 @ $0.22) |
| Nov 25, 2022 | OrbiMed Capital GP V LLC | Director | Sell | $798K (3,629,226 @ $0.22) |
| Nov 25, 2022 | David P Bonita | Director | Sell | $798K (3,629,226 @ $0.22) |
| Nov 23, 2022 | Robert J Alpern | Director | Sell | $28K (131,879 @ $0.21) |
| Nov 23, 2022 | OrbiMed Capital GP V LLC | Director | Sell | $1.2M (5,617,300 @ $0.21) |
| Nov 23, 2022 | David P Bonita | Director | Sell | $1.2M (5,617,300 @ $0.21) |
| Nov 23, 2022 | Orbimed Advisors LLC | Director | Sell | $1.2M (5,617,300 @ $0.21) |
| Nov 22, 2022 | David P Bonita | Director | Sell | $228K (1,034,421 @ $0.22) |
| Nov 22, 2022 | Orbimed Advisors LLC | Director | Sell | $228K (1,034,421 @ $0.22) |
| Nov 22, 2022 | OrbiMed Capital GP V LLC | Director | Sell | $228K (1,034,421 @ $0.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.